Antiplatelet therapy is the mainstay of pharmacologic treatment to prevent thrombotic or
ischemic events in patients with coronary artery disease treated with percutaneous coronary …

Dual antiplatelet therapy (DAPT) represents the standard of care for patients undergoing
percutaneous coronary intervention (PCI). Increasing evidence indicates that a “one-size-fits …

Multiple guidelines and consensus papers have addressed the role of antithrombotic
strategies in patients with established coronary artery disease (CAD). Since evidence and …

Coronary artery disease (CAD) is one of the leading causes of death globally, and
antiplatelet therapy is crucial for both its prevention and treatment. Antiplatelet drugs such as …

Antiplatelet therapy is used in the treatment of patients with acute coronary syndromes,
stroke, and those undergoing percutaneous coronary intervention. Clopidogrel is the most …

BACKGROUND: Platelet function testing has been proposed to better adjust individualized
antiplatelet treatment for patients undergoing endovascular treatment for intracranial …

The key role played by platelets in the atherosclerosis physiopathology, especially in the
acute setting, is ascertained: they are the main actors during thrombus formation and, thus …

Dual antiplatelet therapy (DAPT) is the standard approach to prevent thrombotic events in
patients undergoing percutaneous coronary intervention and presenting with chronic or …

Patients with end-stage renal disease (ESRD) on maintenance dialysis have an increased
risk of ischaemic events, such as recurrent myocardial infarction (MI) and stroke. Potent …

Cardiovascular disease, particularly coronary artery disease (CAD), remains the leading
cause of mortality and morbidity in industrialized countries. Platelet activation and …